{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:03:02Z","timestamp":1792011782406,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82405050"],"award-info":[{"award-number":["82405050"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["U21A20400"],"award-info":[{"award-number":["U21A20400"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82374165"],"award-info":[{"award-number":["82374165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00210-025-04077-z","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T02:09:45Z","timestamp":1743300585000},"page":"12405-12420","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Protective effects of berberine on MASLD: regulation of glucose and lipid metabolism through PI3K\/Akt and STING pathways"],"prefix":"10.1007","volume":"398","author":[{"given":"Jing","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fafeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"issue":"46","key":"4077_CR1","doi-asserted-by":"publisher","first-page":"12196","DOI":"10.1073\/pnas.1708744114","volume":"114","author":"J Bai","year":"2017","unstructured":"Bai J, Cervantes C, Liu J et al (2017) DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway. Proc Natl Acad Sci U S A 114(46):12196\u201312201","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"4077_CR2","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3390\/ijms20071660","volume":"20","author":"A Bort","year":"2019","unstructured":"Bort A, S\u00e1nchez BG, Mateos-G\u00f3mez PA et al (2019) Capsaicin targets lipogenesis in HepG2 cells through AMPK activation, AKT inhibition and PPARs regulation. Int J Mol Sci 20(7):1660","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4077_CR3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00125-017-4223-5","volume":"60","author":"J Braune","year":"2017","unstructured":"Braune J, Weyer U, Matz-Soja M et al (2017) Hedgehog signalling in myeloid cells impacts on body weight, adipose tissue inflammation and glucose metabolism. Diabetologia 60(5):889\u2013899","journal-title":"Diabetologia"},{"issue":"9","key":"4077_CR4","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout A, Katz JD, Venkatraman S et al (2021) The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol 21(9):548\u2013569","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"4077_CR5","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3390\/nu12061712","volume":"12","author":"KX Ding","year":"2020","unstructured":"Ding KX, Gao TL, Xu R et al (2020) Quantifying the effect of supplementation with algae and its extracts on glycolipid metabolism: a meta-analysis of randomized controlled trials. Nutrients 12(6):1712","journal-title":"Nutrients"},{"issue":"14","key":"4077_CR6","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.devcel.2022.06.003","volume":"57","author":"R Donne","year":"2022","unstructured":"Donne R, Saroul-Ainama M, Cordier P et al (2022) Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD. Dev Cell 57(14):1728-1741.e6","journal-title":"Dev Cell"},{"key":"4077_CR7","doi-asserted-by":"publisher","first-page":"154135","DOI":"10.1016\/j.phymed.2022.154135","volume":"101","author":"Y Dou","year":"2022","unstructured":"Dou Y, Ai G, Huang R et al (2022) In vitro and in vivo hypoglycemia effect of oxyberberine, a novel HO-1 agonist: a renewed evidence linking HO-1 to diabetes mellitus. Phytomedicine 101:154135","journal-title":"Phytomedicine"},{"issue":"1","key":"4077_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK et al (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73(1):202\u2013209","journal-title":"J Hepatol"},{"issue":"15","key":"4077_CR9","doi-asserted-by":"publisher","first-page":"5681","DOI":"10.7150\/ijbs.65044","volume":"18","author":"T Fang","year":"2022","unstructured":"Fang T, Wang H, Pan X et al (2022) Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies. Int J Biol Sci 18(15):5681\u20135697","journal-title":"Int J Biol Sci"},{"key":"4077_CR10","doi-asserted-by":"publisher","first-page":"594852","DOI":"10.3389\/fphar.2020.594852","volume":"11","author":"X Feng","year":"2020","unstructured":"Feng X, Wang K, Cao S et al (2020) Pharmacokinetics and excretion of berberine and its nine metabolites in rats. Front Pharmacol 11:594852","journal-title":"Front Pharmacol"},{"issue":"11","key":"4077_CR11","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/ijms21113863","volume":"21","author":"H Fujii","year":"2020","unstructured":"Fujii H, Kawada N (2020) Japan Study Group of Nafld J-N. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int J Mol Sci 21(11):3863","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4077_CR12","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.cell.2013.04.046","volume":"153","author":"P Gao","year":"2013","unstructured":"Gao P, Ascano M, Wu Y et al (2013) Cyclic [G(2\u2019,5\u2019)pA(3\u2019,5\u2019)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 153(5):1094\u2013107","journal-title":"Cell"},{"key":"4077_CR13","doi-asserted-by":"publisher","first-page":"118263","DOI":"10.1016\/j.jep.2024.118263","volume":"331","author":"Y Gao","year":"2024","unstructured":"Gao Y, Sun YY, Bai D et al (2024) Mechanism of the components compatibility of Scutellariae Radix and Coptidis Rhizoma on mice with hyperlipidemia by regulating the Cyp4a family. J Ethnopharmacol 331:118263","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"4077_CR14","doi-asserted-by":"publisher","first-page":"165855","DOI":"10.1016\/j.bbadis.2020.165855","volume":"1866","author":"Y Gong","year":"2020","unstructured":"Gong Y, Li G, Tao J et al (2020) Double knockout of Akt2 and AMPK accentuates high fat diet-induced cardiac anomalies through a cGAS-STING-mediated mechanism. Biochim Biophys Acta Mol Basis Dis 1866(10):165855","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"11","key":"4077_CR15","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s42255-021-00493-6","volume":"3","author":"GF Grabner","year":"2021","unstructured":"Grabner GF, Xie H, Schweiger M et al (2021) Lipolysis: cellular mechanisms for lipid mobilization from fat stores. Nat Metab 3(11):1445\u20131465","journal-title":"Nat Metab"},{"key":"4077_CR16","doi-asserted-by":"publisher","first-page":"104722","DOI":"10.1016\/j.phrs.2020.104722","volume":"155","author":"S Habtemariam","year":"2020","unstructured":"Habtemariam S (2020) Berberine pharmacology and the gut microbiota: a hidden therapeutic link. Pharmacol Res 155:104722","journal-title":"Pharmacol Res"},{"key":"4077_CR17","doi-asserted-by":"publisher","first-page":"775084","DOI":"10.3389\/fphar.2021.775084","volume":"12","author":"L He","year":"2021","unstructured":"He L, Zhong Z, Chen M et al (2021) Current advances in Coptidis Rhizoma for gastrointestinal and other cancers. Front Pharmacol 12:775084","journal-title":"Front Pharmacol"},{"key":"4077_CR18","doi-asserted-by":"publisher","first-page":"842879","DOI":"10.3389\/fphar.2022.842879","volume":"13","author":"Q He","year":"2022","unstructured":"He Q, Chen B, Wang G et al (2022) Co-crystal of rosiglitazone with berberine ameliorates hyperglycemia and insulin resistance through the PI3K\/AKT\/TXNIP pathway in vivo and in vitro. Front Pharmacol 13:842879","journal-title":"Front Pharmacol"},{"issue":"1","key":"4077_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13046-017-0666-2","volume":"36","author":"Y Huang","year":"2017","unstructured":"Huang Y, Zhang J, Hou L et al (2017) LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K\/Akt signaling pathway. J Exp Clin Cancer Res 36(1):194","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"4077_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tem.2011.10.004","volume":"23","author":"TI Jeon","year":"2012","unstructured":"Jeon TI, Osborne TF (2012) SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab 23(2):65\u201372","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"4077_CR21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","volume":"84","author":"SJ Keam","year":"2024","unstructured":"Keam SJ (2024) Resmetirom: first approval. Drugs 84(6):729\u2013735","journal-title":"Drugs"},{"issue":"17","key":"4077_CR22","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.3390\/nu14173459","volume":"14","author":"A Koperska","year":"2022","unstructured":"Koperska A, Weso\u0142ek A, Moszak M et al (2022) Berberine in non-alcoholic fatty liver disease-a review. Nutrients 14(17):3459","journal-title":"Nutrients"},{"issue":"1","key":"4077_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41467-020-20500-w","volume":"12","author":"A Kumar","year":"2021","unstructured":"Kumar A, Sundaram K, Mu J et al (2021) High-fat diet-induced upregulation of exosomal phosphatidylcholine contributes to insulin resistance. Nat Commun 12(1):213","journal-title":"Nat Commun"},{"issue":"9","key":"4077_CR24","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3390\/pharmaceutics12090882","volume":"12","author":"M Kwon","year":"2020","unstructured":"Kwon M, Lim DY, Lee CH et al (2020) Enhanced intestinal absorption and pharmacokinetic modulation of berberine and its metabolites through the inhibition of P-glycoprotein and intestinal metabolism in rats using a berberine mixed micelle formulation. Pharmaceutics 12(9):882","journal-title":"Pharmaceutics"},{"issue":"10","key":"4077_CR25","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.3390\/nu14102032","volume":"14","author":"M Lages","year":"2022","unstructured":"Lages M, Barros R, Moreira P et al (2022) Metabolic effects of an oral glucose tolerance test compared to the mixed meal tolerance tests: a narrative review. Nutrients 14(10):2032","journal-title":"Nutrients"},{"issue":"2","key":"4077_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/hep.31749","volume":"74","author":"T Lan","year":"2021","unstructured":"Lan T, Yu Y, Zhang J et al (2021) Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP-activated protein kinase signaling pathway. Hepatology 74(2):686\u2013703","journal-title":"Hepatology"},{"issue":"2","key":"4077_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.bbrc.2020.03.034","volume":"526","author":"YN Li","year":"2020","unstructured":"Li YN, Su Y (2020) Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING. Biochem Biophys Res Commun 526(2):381\u2013388","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"4077_CR28","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1002\/ptr.7806","volume":"37","author":"Z Li","year":"2023","unstructured":"Li Z, Wang Y, Xu Q et al (2023) Berberine and health outcomes: an umbrella review. Phytother Res 37(5):2051\u20132066","journal-title":"Phytother Res"},{"issue":"1","key":"4077_CR29","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1038\/s41467-023-42420-1","volume":"14","author":"Z Lin","year":"2023","unstructured":"Lin Z, Yang P, Hu Y et al (2023) RING finger protein 13 protects against nonalcoholic steatohepatitis by targeting STING-relayed signaling pathways. Nat Commun 14(1):6635","journal-title":"Nat Commun"},{"key":"4077_CR30","doi-asserted-by":"publisher","first-page":"108593","DOI":"10.1016\/j.pharmthera.2024.108593","volume":"254","author":"X Lin","year":"2024","unstructured":"Lin X, Zhang J, Chu Y et al (2024) Berberine prevents NAFLD and HCC by modulating metabolic disorders. Pharmacol Ther 254:108593","journal-title":"Pharmacol Ther"},{"issue":"9","key":"4077_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","volume":"11","author":"R Liu","year":"2020","unstructured":"Liu R, Chen Y, Liu G et al (2020) PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis 11(9):797","journal-title":"Cell Death Dis"},{"key":"4077_CR32","doi-asserted-by":"publisher","first-page":"102305","DOI":"10.1016\/j.redox.2022.102305","volume":"52","author":"Z Liu","year":"2022","unstructured":"Liu Z, Wang M, Wang X et al (2022) XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury. Redox Biol 52:102305","journal-title":"Redox Biol"},{"issue":"9","key":"4077_CR33","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.molcel.2023.03.029","volume":"83","author":"S Liu","year":"2023","unstructured":"Liu S, Yang B, Hou Y et al (2023) The mechanism of STING autoinhibition and activation. Mol Cell 83(9):1502-1518.e10","journal-title":"Mol Cell"},{"issue":"10","key":"4077_CR34","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI (2021) Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184(10):2537\u20132564","journal-title":"Cell"},{"issue":"6","key":"4077_CR35","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1053\/j.gastro.2018.09.010","volume":"155","author":"X Luo","year":"2018","unstructured":"Luo X, Li H, Ma L et al (2018) Expression of STING is increased in liver tissues from patients with NAFLD and promotes macrophage-mediated hepatic inflammation and fibrosis in mice. Gastroenterology 155(6):1971-1984.e4","journal-title":"Gastroenterology"},{"issue":"11","key":"4077_CR36","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.1002\/jps.23718","volume":"102","author":"JY Ma","year":"2013","unstructured":"Ma JY, Feng R, Tan XS et al (2013) Excretion of berberine and its metabolites in oral administration in rats. J Pharm Sci 102(11):4181\u201392","journal-title":"J Pharm Sci"},{"issue":"5","key":"4077_CR37","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/ATVBAHA.117.309017","volume":"37","author":"Y Mao","year":"2017","unstructured":"Mao Y, Luo W, Zhang L et al (2017) STING-IRF3 triggers endothelial inflammation in response to free fatty acid-induced mitochondrial damage in diet-induced obesity. Arterioscler Thromb Vasc Biol 37(5):920\u2013929","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4077_CR38","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev-physiol-060721-092930","volume":"84","author":"G Marcelin","year":"2022","unstructured":"Marcelin G, Gautier EL, Cl\u00e9ment K (2022) Adipose tissue fibrosis in obesity: etiology and challenges. Annu Rev Physiol 84:135\u2013155","journal-title":"Annu Rev Physiol"},{"key":"4077_CR39","doi-asserted-by":"publisher","first-page":"154770","DOI":"10.1016\/j.metabol.2021.154770","volume":"119","author":"E Muzurovi\u0107","year":"2021","unstructured":"Muzurovi\u0107 E, Mikhailidis DP, Mantzoros C (2021) Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism 119:154770","journal-title":"Metabolism"},{"issue":"1","key":"4077_CR40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.apsb.2021.05.011","volume":"12","author":"PK Oduro","year":"2022","unstructured":"Oduro PK, Zheng X, Wei J et al (2022) The cGAS-STING signaling in cardiovascular and metabolic diseases: future novel target option for pharmacotherapy. Acta Pharm Sin B 12(1):50\u201375","journal-title":"Acta Pharm Sin B"},{"issue":"10290","key":"4077_CR41","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M (2021) Non-alcoholic fatty liver disease[. Lancet 397(10290):2212\u20132224","journal-title":"Lancet"},{"key":"4077_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.metabol.2017.09.010","volume":"81","author":"JT Qiao","year":"2018","unstructured":"Qiao JT, Cui C, Qing L et al (2018) Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease. Metabolism 81:13\u201324","journal-title":"Metabolism"},{"issue":"1","key":"4077_CR43","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1038\/s41467-022-33842-4","volume":"13","author":"M Sakaguchi","year":"2022","unstructured":"Sakaguchi M, Okagawa S, Okubo Y et al (2022) Phosphatase protector alpha4 (\u03b14) is involved in adipocyte maintenance and mitochondrial homeostasis through regulation of insulin signaling. Nat Commun 13(1):6092","journal-title":"Nat Commun"},{"key":"4077_CR44","doi-asserted-by":"publisher","first-page":"114244","DOI":"10.1016\/j.biopha.2023.114244","volume":"159","author":"MS Savova","year":"2023","unstructured":"Savova MS, Mihaylova LV, Tews D et al (2023) Targeting PI3K\/AKT signaling pathway in obesity. Biomed Pharmacother 159:114244","journal-title":"Biomed Pharmacother"},{"issue":"8039","key":"4077_CR45","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41586-024-08031-6","volume":"635","author":"AE Schade","year":"2024","unstructured":"Schade AE, Perurena N, Yang Y et al (2024) AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution. Nature 635(8039):755\u2013763","journal-title":"Nature"},{"issue":"2","key":"4077_CR46","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.celrep.2015.09.007","volume":"13","author":"GJ Seo","year":"2015","unstructured":"Seo GJ, Yang A, Tan B et al (2015) Akt kinase-mediated checkpoint of cGAS DNA sensing pathway. Cell Rep 13(2):440\u20139","journal-title":"Cell Rep"},{"issue":"1","key":"4077_CR47","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.1080\/21655979.2021.1987130","volume":"12","author":"T Song","year":"2021","unstructured":"Song T, Chen WD (2021) Berberine inhibited carotid atherosclerosis through PI3K\/AKTmTOR signaling pathway. Bioengineered 12(1):8135\u20138146","journal-title":"Bioengineered"},{"issue":"5","key":"4077_CR48","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11684-019-0724-6","volume":"14","author":"D Song","year":"2020","unstructured":"Song D, Hao J, Fan D (2020) Biological properties and clinical applications of berberine. Front Med 14(5):564\u2013582","journal-title":"Front Med"},{"issue":"4","key":"4077_CR49","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","volume":"10","author":"N Stefan","year":"2022","unstructured":"Stefan N, Cusi K (2022) A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol 10(4):284\u2013296","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"4077_CR50","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10555-023-10156-5","volume":"43","author":"F Su","year":"2024","unstructured":"Su F, Koeberle A (2024) Regulation and targeting of SREBP-1 in hepatocellular carcinoma. Cancer Metastasis Rev 43(2):673\u2013708","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"4077_CR51","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","volume":"6","author":"G Targher","year":"2021","unstructured":"Targher G, Tilg H, Byrne CD (2021) Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatol 6(7):578\u2013588","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"4077_CR52","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD et al (2021) The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol 18(9):599\u2013612","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"4077_CR53","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41401-022-00874-x","volume":"43","author":"XF Tong","year":"2022","unstructured":"Tong XF, Wang QY, Zhao XY et al (2022) Histological assessment based on liver biopsy: the value and challenges in NASH drug development. Acta Pharmacol Sin 43(5):1200\u20131209","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"4077_CR54","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","volume":"49","author":"K Wang","year":"2017","unstructured":"Wang K, Feng X, Chai L et al (2017) The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab Rev 49(2):139\u2013157","journal-title":"Drug Metab Rev"},{"issue":"5","key":"4077_CR55","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1017\/S0007114520003025","volume":"125","author":"L Wang","year":"2021","unstructured":"Wang L, Xu B, Sagada G et al (2021) Dietary berberine regulates lipid metabolism in muscle and liver of black sea bream (Acanthopagrus schlegelii) fed normal or high-lipid diets. Br J Nutr 125(5):481\u2013493","journal-title":"Br J Nutr"},{"key":"4077_CR56","doi-asserted-by":"publisher","first-page":"122645","DOI":"10.1016\/j.biomaterials.2024.122645","volume":"311","author":"H Wang","year":"2024","unstructured":"Wang H, Liu Z, Fang Y et al (2024) Spatiotemporal release of non-nucleotide STING agonist and AKT inhibitor from implantable 3D-printed scaffold for amplified cancer immunotherapy. Biomaterials 311:122645","journal-title":"Biomaterials"},{"issue":"8","key":"4077_CR57","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41556-019-0352-z","volume":"21","author":"S Wu","year":"2019","unstructured":"Wu S, Zhang Q, Zhang F et al (2019) HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity. Nat Cell Biol 21(8):1027\u20131040","journal-title":"Nat Cell Biol"},{"issue":"1","key":"4077_CR58","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41413-022-00194-0","volume":"10","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Li J, Liao X et al (2022) RIOX1-demethylated cGAS regulates ionizing radiation-elicited DNA repair[. Bone Res 10(1):19","journal-title":"Bone Res"},{"issue":"1","key":"4077_CR59","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1142\/S0192415X24500113","volume":"52","author":"WL Yang","year":"2024","unstructured":"Yang WL, Zhang CY, Ji WY et al (2024) Berberine metabolites stimulate GLP-1 secretion by alleviating oxidative stress and mitochondrial dysfunction. Am J Chin Med 52(1):253\u2013274","journal-title":"Am J Chin Med"},{"issue":"5","key":"4077_CR60","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1097\/HEP.0000000000000638","volume":"80","author":"T Yang","year":"2024","unstructured":"Yang T, Qu X, Wang X et al (2024) The macrophage STING-YAP axis controls hepatic steatosis by promoting the autophagic degradation of lipid droplets. Hepatology 80(5):1169\u20131183","journal-title":"Hepatology"},{"issue":"4","key":"4077_CR61","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, De Avila L et al (2019) The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 71(4):793\u2013801","journal-title":"J Hepatol"},{"issue":"7","key":"4077_CR62","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.7150\/ijbs.54604","volume":"17","author":"M Yu","year":"2021","unstructured":"Yu M, Alimujiang M, Hu L et al (2021) Berberine alleviates lipid metabolism disorders via inhibition of mitochondrial complex I in gut and liver. Int J Biol Sci 17(7):1693\u20131707","journal-title":"Int J Biol Sci"},{"issue":"8","key":"4077_CR63","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41422-020-0346-1","volume":"30","author":"S Yum","year":"2020","unstructured":"Yum S, Li M, Chen ZJ (2020) Old dogs, new trick: classic cancer therapies activate cGAS. Cell Res 30(8):639\u2013648","journal-title":"Cell Res"},{"issue":"1","key":"4077_CR64","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41392-022-01252-z","volume":"7","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Zhou H, Ouyang X et al (2022) Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy. Signal Transduct Target Ther 7(1):394","journal-title":"Signal Transduct Target Ther"},{"issue":"19","key":"4077_CR65","doi-asserted-by":"publisher","first-page":"14700","DOI":"10.3390\/ijms241914700","volume":"24","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li X, Liu X et al (2023) High-carbohydrate diet consumption poses a more severe liver cholesterol deposition than a high-fat and high-calorie diet in mice. Int J Mol Sci 24(19):14700","journal-title":"Int J Mol Sci"},{"key":"4077_CR66","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jhep.2024.08.008","volume":"82","author":"YH Zhang","year":"2024","unstructured":"Zhang YH, Xie R, Dai CS et al (2024) Thyroid hormone receptor-beta agonist HSK31679 alleviates MASLD by modulating gut microbial sphingolipids. J Hepatol 82:189","journal-title":"J Hepatol"},{"key":"4077_CR67","doi-asserted-by":"publisher","first-page":"114311","DOI":"10.1016\/j.biopha.2023.114311","volume":"160","author":"X Zhao","year":"2023","unstructured":"Zhao X, Amevor FK, Cui Z et al (2023) Steatosis in metabolic diseases: a focus on lipolysis and lipophagy. Biomed Pharmacother 160:114311","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4077_CR68","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41577-022-00751-y","volume":"23","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Simon M, Seluanov A et al (2023) DNA damage and repair in age-related inflammation. Nat Rev Immunol 23(2):75\u201389","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"4077_CR69","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1080\/15548627.2020.1757955","volume":"17","author":"ZG Zheng","year":"2021","unstructured":"Zheng ZG, Zhu ST, Cheng HM et al (2021) Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway. Autophagy 17(7):1592\u20131613","journal-title":"Autophagy"},{"issue":"4","key":"4077_CR70","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.tcb.2021.10.008","volume":"32","author":"Q Zhu","year":"2022","unstructured":"Zhu Q, An YA, Scherer PE (2022) Mitochondrial regulation and white adipose tissue homeostasis. Trends Cell Biol 32(4):351\u2013364","journal-title":"Trends Cell Biol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04077-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04077-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04077-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T06:02:23Z","timestamp":1758261743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04077-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4077"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04077-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving experimental animals were conducted in accordance with the ethical requirements set forth by the Animal Experimental Ethics Committee at Beijing University of Chinese Medicine. Animal license number: BUCM-4\u20132022090903-3083.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All data were done in own laboratory, and all the authors were informed about the submission and publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}